Literature DB >> 33606075

The storage stability of Bacillus subtilis spore displaying cysteine protease of Clonorchis sinensis and its effect on improving the gut microbiota of mice.

Zeli Tang1,2,3, Zhanshuai Wu4, Hengchang Sun5, Lu Zhao6, Mei Shang5, Mengchen Shi2,3, Hongye Jiang2,3, Zhipeng Lin2,3, Xinyi Zhou2,3, Xuerong Li2,3, Xinbing Yu7,8, Yan Huang9,10.   

Abstract

Bacillus subtilis (B. subtilis) spore can serve as an ideal vehicle for expressing heterologous antigens, and elicit specific immune responses by oral administration. In previous studies, we successfully constructed the recombinant B. subtilis spores expressing cysteine protease of Clonorchis sinensis (C. sinensis, B.s-CsCP), and confirmed that oral administration of B.s-CsCP could elicit good protective immune responses in mice. In this study, Gram staining was used to observe the morphology of B.s-CsCP in different form, and the storage of liquid spores and lyophilized spores at different temperatures was compared. The mice were orally immunized with three different doses of spores (2×108, 1×109, and 5×109 CFU/day) for three times in total at biweekly interval. Then, antibody levels of mice were measured, the safety of spores was evaluated, and the changes of gut microbiota after oral gavage of spores (1×109 dose) were investigated. Results showed that B. subtilis was a typical Gram-positive bacterium, and its spore had good resistance to chemical dye. Liquid B. subtilis spores resuspended in sterile water could be stored for a long time at 4 °C or below, while lyophilized spores could be well stored even at RT and better at lower temperatures. Oral administration of B. subtilis spores to mice could stimulate both local mucosal and systemic immune responses in a dose-dependent manner without toxic side effects. Besides, beneficial bacteria producing butyrate such as Odoribacter were increased, while potential pathogens such as Escherichia-Shigella were decreased in mice intestine. Therefore, our work further confirmed that B. subtilis spores expressing CsCP could be a promising oral vaccine against C. sinensis with the advantages of stability, safety, easy storage, and promotion of intestinal health.Key Points• Recombinant CsCP B. subtilis spores could be easily preserved in either liquid or freeze-dried state.• Oral immunization of recombinant spores in mice could increase both local and system immune levels in a dose-dependent manner.• Oral administration of recombinant spores increased the number of beneficial bacteria and reduced the number of harmful bacteria in the intestinal tract of mice.

Entities:  

Keywords:  Bacillus subtilis spore; Cysteine protease of Clonorchis sinensis; Gut microbiota; Oral vaccine; Storage

Mesh:

Substances:

Year:  2021        PMID: 33606075     DOI: 10.1007/s00253-021-11126-z

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  40 in total

1.  UPARSE: highly accurate OTU sequences from microbial amplicon reads.

Authors:  Robert C Edgar
Journal:  Nat Methods       Date:  2013-08-18       Impact factor: 28.547

Review 2.  Bacillus subtilis Spore Surface Display Technology: A Review of Its Development and Applications.

Authors:  Zhang Guoyan; An Yingfeng; Hossain Zabed; Guo Qi; Miaomiao Yang; Yuan Jiao; Wen Li; Sun Wenjing; Qi Xianghui
Journal:  J Microbiol Biotechnol       Date:  2019-02-28       Impact factor: 2.351

Review 3.  Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens.

Authors:  Hellen Amuguni; Saul Tzipori
Journal:  Hum Vaccin Immunother       Date:  2012-06-15       Impact factor: 3.452

4.  Effect of dietary Bacillus subtilis on proportion of Bacteroidetes and Firmicutes in swine intestine and lipid metabolism.

Authors:  C Cui; C J Shen; G Jia; K N Wang
Journal:  Genet Mol Res       Date:  2013-05-23

Review 5.  Role of the normal gut microbiota.

Authors:  Sai Manasa Jandhyala; Rupjyoti Talukdar; Chivkula Subramanyam; Harish Vuyyuru; Mitnala Sasikala; D Nageshwar Reddy
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

6.  The safety of Bacillus subtilis and Bacillus indicus as food probiotics.

Authors:  H A Hong; J-M Huang; R Khaneja; L V Hiep; M C Urdaci; S M Cutting
Journal:  J Appl Microbiol       Date:  2008-02-29       Impact factor: 3.772

7.  Impact of short-term overfeeding of saturated or unsaturated fat or sugars on the gut microbiota in relation to liver fat in obese and overweight adults.

Authors:  Ching Jian; Panu Luukkonen; Sanja Sädevirta; Hannele Yki-Järvinen; Anne Salonen
Journal:  Clin Nutr       Date:  2020-05-16       Impact factor: 7.324

8.  Bacillus subtilis 29784 induces a shift in broiler gut microbiome toward butyrate-producing bacteria and improves intestinal histomorphology and animal performance.

Authors:  V Jacquier; A Nelson; M Jlali; L Rhayat; K S Brinch; E Devillard
Journal:  Poult Sci       Date:  2019-06-01       Impact factor: 3.352

9.  QIIME allows analysis of high-throughput community sequencing data.

Authors:  J Gregory Caporaso; Justin Kuczynski; Jesse Stombaugh; Kyle Bittinger; Frederic D Bushman; Elizabeth K Costello; Noah Fierer; Antonio Gonzalez Peña; Julia K Goodrich; Jeffrey I Gordon; Gavin A Huttley; Scott T Kelley; Dan Knights; Jeremy E Koenig; Ruth E Ley; Catherine A Lozupone; Daniel McDonald; Brian D Muegge; Meg Pirrung; Jens Reeder; Joel R Sevinsky; Peter J Turnbaugh; William A Walters; Jeremy Widmann; Tanya Yatsunenko; Jesse Zaneveld; Rob Knight
Journal:  Nat Methods       Date:  2010-04-11       Impact factor: 28.547

Review 10.  Cell Cycle Machinery in Bacillus subtilis.

Authors:  Jeff Errington; Ling Juan Wu
Journal:  Subcell Biochem       Date:  2017
View more
  2 in total

1.  Potential Gut Microbiota Features for Non-Invasive Detection of Schistosomiasis.

Authors:  Datao Lin; Qiuyue Song; Jiahua Liu; Fang Chen; Yishu Zhang; Zhongdao Wu; Xi Sun; Xiaoying Wu
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

2.  Surface Display of porcine circovirus type 2 antigen protein cap on the spores of bacillus subtilis 168: An effective mucosal vaccine candidate.

Authors:  Weijie Li; Jianzhen Li; Xixi Dai; Minggang Liu; Abdul Khalique; Zhenghua Wang; Yan Zeng; Dongmei Zhang; Xueqin Ni; Dong Zeng; Bo Jing; Kangcheng Pan
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.